| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/27/2013 | EP2560994A2 Antibodies to cd122 |
| 02/27/2013 | EP2560980A2 Osmium (ii) arene azo anti-cancer complexes |
| 02/27/2013 | EP2560976A1 Furopyridine compounds and uses thereof |
| 02/27/2013 | EP2560972A2 Compounds and methods for kinase modulation, and indications therefor |
| 02/27/2013 | EP2560971A1 Pyrrolopyridine inhibitors of kinases |
| 02/27/2013 | EP2560967A1 Heterocyclic carboxylic acid amides as pdk1 inihibitors |
| 02/27/2013 | EP2560949A1 Tranylcypromine derivatives as inhibitors of histone demethylase lsd1 and/or lsd2 |
| 02/27/2013 | EP2560947A1 Lysine specific demethylase-1 inhibitors and their use |
| 02/27/2013 | EP2560688A1 Combination of drugs with protein-binding prodrugs |
| 02/27/2013 | EP2560683A2 Production of heteromultimeric proteins |
| 02/27/2013 | EP2560672A1 Rtef-1 variants and uses thereof |
| 02/27/2013 | EP2560667A1 Method to detect endothelial cell massive calcium accumulation death |
| 02/27/2013 | EP2560659A2 Compositions and method for the treatment of multiple myeloma |
| 02/27/2013 | EP2560658A2 Methods of enhancing antibody-dependent cellular cytotoxicity |
| 02/27/2013 | EP2560648A2 Method for treating pancreatic cancer |
| 02/27/2013 | EP2560647A2 Combination therapy with a proteasome inhibitor and a gallium complex |
| 02/27/2013 | EP2560645A2 Novel conjugates of cc-1065 analogs and bifunctional linkers |
| 02/27/2013 | EP2560641A2 Cancer therapy using a combination of a hsp90 inhibitory compounds and a vegf inhibitor |
| 02/27/2013 | EP2560640A1 Cancer therapy using a combination of a hsp90 inhibitory compounds and a egfr inhibitor |
| 02/27/2013 | EP2560639A2 Method of treating prostate cancer |
| 02/27/2013 | EP2560638A2 Method of treating gastric cancer |
| 02/27/2013 | EP2560637A2 Methods for identifying and using inhibitors of casein kinase 1 epsilon isoform for inhibiting the growth and/or proliferation of myc-driven tumor cells |
| 02/27/2013 | EP2560627A1 Use of bis [thiohydrazide amide]compounds such as elesclomol for treating cancers |
| 02/27/2013 | EP2540745A9 Fully humanized anti-her2 antibody, preparation method and use thereof |
| 02/27/2013 | EP2143444A9 Compositions for inhibition of angiogenesis |
| 02/27/2013 | CN202751611U Diffused particle for treating esophagus cancer |
| 02/27/2013 | CN102947441A Cellular constituents from bacteroides, compositions thereof, and therapeutic methods employing bacteroides or cellular constituents thereof |
| 02/27/2013 | CN102947338A Neutralizing prolactin receptor antibodies and their therapeutic use |
| 02/27/2013 | CN102947337A Methods for treating colorectal cancer |
| 02/27/2013 | CN102947326A Ccn3 peptides and analogs thereof for therapeutic use |
| 02/27/2013 | CN102947322A Anticancer steroidal lactones unsaturated in position 7 (8) |
| 02/27/2013 | CN102947316A Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activity |
| 02/27/2013 | CN102947315A Inhibitors of protein tyrosine kinase activity |
| 02/27/2013 | CN102947308A Polymorphs of OSI-906 |
| 02/27/2013 | CN102947305A Compounds and methods for kinase modulation, and indications therefor |
| 02/27/2013 | CN102947302A Triazolo [4, 5 - b] pyridin derivatives |
| 02/27/2013 | CN102947292A Nitrogen containing heteroaryl compounds |
| 02/27/2013 | CN102947290A Sulfonamido derivatives of 3,4-diarylpyrazoles as protein kinase inhibitors |
| 02/27/2013 | CN102947285A Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
| 02/27/2013 | CN102947283A Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 02/27/2013 | CN102947272A 2 -aminopyridine derivatives useful as inhibitors of atr kinase |
| 02/27/2013 | CN102947268A Indolyl or indolinyl hydroxamate compounds |
| 02/27/2013 | CN102947265A Lysine specific demethylase-1 inhibitors and their use |
| 02/27/2013 | CN102946908A Inhibitor of expression of dominant allele |
| 02/27/2013 | CN102946906A Production of heteromultimeric proteins |
| 02/27/2013 | CN102946902A Bispecific antibodies |
| 02/27/2013 | CN102946898A Agent for reducing acetaldehyde in oral cavity |
| 02/27/2013 | CN102946880A Method for treating pancreatic cancer |
| 02/27/2013 | CN102946879A Combination therapy with a proteasome inhibitor and a gallium complex |
| 02/27/2013 | CN102946878A Method of treating prostate cancer |
| 02/27/2013 | CN102946861A Concentrated protein formulations and uses thereof |
| 02/27/2013 | CN102943108A Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer |
| 02/27/2013 | CN102943067A Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 02/27/2013 | CN102942635A Extraction method of high cell apoptosis induction active lycium barbarum polysaccharide |
| 02/27/2013 | CN102942631A Humanized anti-cmet antagonists |
| 02/27/2013 | CN102942618A Telomeric protein polypeptide fragment with tumor cell killing activity and application thereof |
| 02/27/2013 | CN102942608A Preparation method and application of water-soluble dipyrrole compound |
| 02/27/2013 | CN102942605A Preparation method and application of Jasminum lanceolarium medium-ring iridoids |
| 02/27/2013 | CN102942595A Ruthenium complexes, preparation method thereof and application |
| 02/27/2013 | CN102942594A Anti-cancer medicinal aspirin platinum complex and preparation method thereof |
| 02/27/2013 | CN102942589A Salts of isophosphoramide mustard and analogs thereof |
| 02/27/2013 | CN102942570A 1-trifluoromethyl-2,8-diazospiro[4.5]decane derivative and preparation method thereof |
| 02/27/2013 | CN102942567A Disodium salt crystal of pyrroloquinoline quinone |
| 02/27/2013 | CN102942561A 4-amino quinazoline heterocyclic compound and purpose of 4-amino quinazoline heterocyclic compound |
| 02/27/2013 | CN102942554A Homopiperony lamine condensed salicylaldehyde and synthesis method and application of homopiperony lamine condensed salicylaldehyde |
| 02/27/2013 | CN102942552A 3,11-disubstituted-14-aryl-14H-dibenzo[a,j]xanthene derivatives, preparation methods and uses thereof |
| 02/27/2013 | CN102942535A 4-tertiary butyl-5-(2-nitroxyethyl)-2-aminothiazole, as well as preparation method and application thereof |
| 02/27/2013 | CN102942530A Novel anti-tumor compound and medication composition thereof |
| 02/27/2013 | CN102942529A 4-(4-substituted piperazine)-5,6,7-trialkoxy quinazoline type compound as well as preparation method and application of 4-(4-substituted piperazine)-5,6,7-trialkoxy quinazoline type compound |
| 02/27/2013 | CN102942522A Heterocyclic inhibitors of mek and methods of use thereof |
| 02/27/2013 | CN102942516A Alkaloid compound and preparation method and application of alkaloid compound |
| 02/27/2013 | CN102942515A Ethane bridged indole compound, synthetic method and application thereof |
| 02/27/2013 | CN102942514A Ionone keto-double-chalcone thiosemicarbazone and production method thereof |
| 02/27/2013 | CN102940892A Preparation method of targeting porphyrin fluorescent molecule and gold nanorod dyad |
| 02/27/2013 | CN102940891A Lipids, lipid complexes and use thereof |
| 02/27/2013 | CN102940890A Gene application in inhibition and apoptosis of glioma cell |
| 02/27/2013 | CN102940889A Drug conjugate composition |
| 02/27/2013 | CN102940888A Targeted drug delivery method of pectin colon containing lecithin |
| 02/27/2013 | CN102940886A Biological barrier penetrating agent and preparation method thereof |
| 02/27/2013 | CN102940884A Inhibitor for hepatoma carcinoma cell and application to aspect of inhibiting tumor growth thereof |
| 02/27/2013 | CN102940883A Therapeutic composition to improve the effect of the therapy with anti-epidermal growth factor receptor antibodies |
| 02/27/2013 | CN102940880A Growth factor complex |
| 02/27/2013 | CN102940842A Anti-esophageal cancer drug |
| 02/27/2013 | CN102940829A Traditional Chinese medicine composition for curing lung cancer |
| 02/27/2013 | CN102940813A Self-microemulsifying nanocombination comprising lucid ganoderma total triterpene and jobstears seed oil and preparation method and application thereof |
| 02/27/2013 | CN102940808A Prescription medicine for treating lung cancer and preparation method |
| 02/27/2013 | CN102940773A Chinese medicinal preparation for inhibiting liver cancer metastasis and preparation method thereof |
| 02/27/2013 | CN102940765A Medicine for treating breast cancer and preparation method of medicine |
| 02/27/2013 | CN102940748A Composition for treating lymphoma and preparation method of composition |
| 02/27/2013 | CN102940746A Chinese medicament for treating cancers and preparation method thereof |
| 02/27/2013 | CN102940720A Anti-hepatoma traditional Chinese medicine compound preparation |
| 02/27/2013 | CN102940701A Method for extracting pear polyphenol |
| 02/27/2013 | CN102940687A Szechwan Chinaberry fruit extract and application thereof |
| 02/27/2013 | CN102940683A Chinese medicinal compound composition for treating liver cancer and preparation method thereof |
| 02/27/2013 | CN102940682A Drug for treating esophagus cancer and stomach cancer |
| 02/27/2013 | CN102940672A Application of Chinese honey locust spine total flavone in preparation of drugs for preventing and treating tumors |
| 02/27/2013 | CN102940666A Method for preparing cortex albiziae saponin through adopting macroporous resin separation |
| 02/27/2013 | CN102940654A Ternary nano-micelle of flammulina velutipe non-saponification extracted sterol and preparation method thereof |
| 02/27/2013 | CN102940652A Eubacterium biforme preparation and use thereof |
| 02/27/2013 | CN102940651A Method for activation of prodrug by tumor targeting bacteria and use thereof |